Delirium tremens laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Zehra Malik (talk | contribs) No edit summary |
Zehra Malik (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Delirium tremens}} | {{Delirium tremens}} | ||
{{CMG}} {{AE}} {{VVS}} | {{CMG}} {{AE}} {{VVS}} | ||
==Overview== | |||
== Laboratory Findings == | == Laboratory Findings == | ||
=== Electrolyte and Biomarker Studies === | === Electrolyte and Biomarker Studies === | ||
Revision as of 17:10, 21 June 2022
|
Delirium Tremens Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Delirium tremens laboratory findings On the Web |
|
American Roentgen Ray Society Images of Delirium tremens laboratory findings |
|
Risk calculators and risk factors for Delirium tremens laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vishnu Vardhan Serla M.B.B.S. [2]
Overview
Laboratory Findings
Electrolyte and Biomarker Studies
- Complete blood count, differential count
- Drug screening
- Blood lactate levels
- Osmolal gap
- Serum levels of following electrolytes[1]
- Bicarbonate - decrease
- Blood urea nitrogen (BUN) - may increase
- Chloride - may remain unchanged
- Creatine phosphokinase - Some patients develop rhabdomyolysis
- Creatinine - may increase
- Ketones
- Lipase -
- Liver function tests - abnormal
- Magnesium - decrease
- Potassium - decreased
- Sodium - decreased
- CSF examination - ruling out infections of the brain